200 related articles for article (PubMed ID: 6107191)
21. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
Krarup T; Madsbad S; Moody AJ
J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
[TBL] [Abstract][Full Text] [Related]
22. GIP, incretin and gastrointestinal disease.
Lauritsen KB
Dan Med Bull; 1983 Jun; 30(4):205-14. PubMed ID: 6347538
[No Abstract] [Full Text] [Related]
23. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans.
Holst JJ; Gromada J
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E199-206. PubMed ID: 15271645
[TBL] [Abstract][Full Text] [Related]
24. Effect of jejunoileal bypass in the rat on the enteroinsular axis.
Pederson RA; Buchan AM; Zahedi-Asl S; Chan CB; Brown JC
Regul Pept; 1982 Dec; 5(1):53-63. PubMed ID: 6762622
[TBL] [Abstract][Full Text] [Related]
25. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery.
Patriti A; Facchiano E; Sanna A; Gullà N; Donini A
Obes Surg; 2004; 14(6):840-8. PubMed ID: 15318993
[TBL] [Abstract][Full Text] [Related]
26. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
[TBL] [Abstract][Full Text] [Related]
27. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
Vahl T; D'Alessio D
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
[TBL] [Abstract][Full Text] [Related]
28. Hypersecretion of gastric inhibitory polypeptide in nondiabetic children with cystic fibrosis.
Ross SA; Morrison D; McArthur RG
Pediatrics; 1981 Feb; 67(2):252-4. PubMed ID: 7017571
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal peptides--rôle in pathophysiology and disease.
Creutzfeldt W
Scand J Gastroenterol Suppl; 1982; 77():7-20. PubMed ID: 6750831
[TBL] [Abstract][Full Text] [Related]
30. The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus.
Ganda OP
Diabetes Care; 1981; 4(3):435-42. PubMed ID: 6124374
[TBL] [Abstract][Full Text] [Related]
31. Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice.
Shimotoyodome A; Fukuoka D; Suzuki J; Fujii Y; Mizuno T; Meguro S; Tokimitsu I; Hase T
Endocrinology; 2009 May; 150(5):2118-26. PubMed ID: 19179446
[TBL] [Abstract][Full Text] [Related]
32. The role of gastric inhibitory polypeptide in the augmented insulin response to sucrose.
Falko JM; Reynolds JC; O'Dorisio TM; Bossetti B; Cataland S
Diabetes Care; 1982; 5(4):379-85. PubMed ID: 6759077
[TBL] [Abstract][Full Text] [Related]
33. Physiology and pathophysiology of GIP.
Brown JC; Dryburgh JR; Frost JL; Otte SC; Pederson RA
Adv Exp Med Biol; 1978; 106():169-71. PubMed ID: 717160
[No Abstract] [Full Text] [Related]
34. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
Pederson RA; Brown JC
Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
[TBL] [Abstract][Full Text] [Related]
35. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
[TBL] [Abstract][Full Text] [Related]
36. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
Holst JJ
BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
[TBL] [Abstract][Full Text] [Related]
37. [Gluco-incretin hormones in insulin secretion and diabetes].
Thorens B
Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
[TBL] [Abstract][Full Text] [Related]
38. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.
Hansotia T; Drucker DJ
Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432
[TBL] [Abstract][Full Text] [Related]
39. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
40. Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice.
Flatt PR; Bailey CJ; Kwasowski P; Swanston-Flatt SK; Marks V
Diabetes; 1983 May; 32(5):433-5. PubMed ID: 6341126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
